Bierman Century City Medical Los Angeles, CA - 90067

Bierman Century City Medical is categorized under Dermatologists in Los Angeles, CA and active since 1969.

Bierman Century City Medical was established in 1969, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Dermatologists business, which does work in the B2C market, and is classified as a Dermatologists, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Stanley Bierman at the company’s single location by writing to 2080 Century Park East # 1008, Los Angeles, California CA 90067 or by phoning (310) 553-3567. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bierman Century City Medical
Contact Person: Stanley Bierman
Address: 2080 Century Park East # 1008, Los Angeles, California 90067
Phone Number: (310) 553-3567
Annual Revenue (USD): $500.000 to $999.999
Founded: 1969
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Dermatologists
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Bierman Century City Medical was started in 1969 to provide professional Dermatologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Stanley Bierman for inquiries that concern Bierman Century City Medical by calling the company number (310) 553-3567, as your correspondence is most welcome. Additionally, the physical location of the single location of Bierman Century City Medical can be found at the coordinates 34.05886,-118.412266 as well as the street address 2080 Century Park East # 1008 in Los Angeles, California 90067.

For its online presence, you may visit Bierman Century City Medical’s website at and engage with its social media outlets through on Twitter and on Facebook.